| Literature DB >> 25621961 |
Abstract
Sofosbuvir, a nucleotide polymerase inhibitor, was approved in 2013 for treating hepatitis C infection in adults. This article reviews the use of sofosbuvir in combination with ribavirin with or without pegylated interferon.Entities:
Mesh：
Substances：
Year: 2015 PMID： 25621961 DOI： 10.1097/01.JAA.0000459818.09661.c0
Source DB: PubMed Journal: JAAPA ISSN： 0893-7400